Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126193452 | 12619345 | 2 | F | 20150420 | 20160823 | 20160803 | 20160830 | EXP | SE-MYLANLABS-2016M1031151 | MYLAN | 0.00 | Y | 0.00000 | 20160830 | MD | SE | SE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126193452 | 12619345 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, TID | U | 75973 | 500 | MG | TID | ||||||
126193452 | 12619345 | 2 | C | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 3 | C | LEVEMIR | INSULIN DETEMIR | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 4 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 5 | C | BEHEPAN /00056201/ | CYANOCOBALAMIN | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 6 | C | FOLACIN /00024201/ | FOLIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 7 | C | LOGIMAX | FELODIPINEMETOPROLOL SUCCINATE | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 8 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 9 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
126193452 | 12619345 | 11 | C | INDIVINA | 2 | Unknown | UNK | U | 0 | ||||||||||
126193452 | 12619345 | 12 | C | TOVIAZ | FESOTERODINE FUMARATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126193452 | 12619345 | 1 | Type 2 diabetes mellitus |
126193452 | 12619345 | 2 | Product used for unknown indication |
126193452 | 12619345 | 3 | Product used for unknown indication |
126193452 | 12619345 | 4 | Product used for unknown indication |
126193452 | 12619345 | 5 | Product used for unknown indication |
126193452 | 12619345 | 6 | Product used for unknown indication |
126193452 | 12619345 | 7 | Product used for unknown indication |
126193452 | 12619345 | 8 | Product used for unknown indication |
126193452 | 12619345 | 9 | Product used for unknown indication |
126193452 | 12619345 | 10 | Product used for unknown indication |
126193452 | 12619345 | 11 | Product used for unknown indication |
126193452 | 12619345 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126193452 | 12619345 | DE |
126193452 | 12619345 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126193452 | 12619345 | Abdominal pain upper | |
126193452 | 12619345 | Lactic acidosis | |
126193452 | 12619345 | Myocardial infarction | |
126193452 | 12619345 | Nausea | |
126193452 | 12619345 | Poisoning | |
126193452 | 12619345 | Renal failure | |
126193452 | 12619345 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126193452 | 12619345 | 1 | 20080716 | 20150519 | 0 |